仙骨神経刺激の世界市場の規模は2023年に16億ドルと評価され、2024年から2030年にかけて11.5%のCAGRで成長すると予測されます。この市場の成長は、過活動膀胱の発生率の増加と、尿路感染症を含む切迫性尿失禁の発生率によるものですす。また、技術の進歩や仙骨神経刺激（SNS）が有効な治療選択肢として認知されるようになったことで、SNSの普及が進んでいます。また、この市場は、デバイスの有効性と安全性の向上を目的としたメーカーによる臨床研究やイノベーションの促進にも支えられています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Sacral Nerve Stimulation Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Sacral Nerve Stimulation Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Sacral Nerve Stimulation Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Sacral Nerve Stimulation Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Implantable SNS Devices
4.3.1. Implantable SNS Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. External SNS Devices
4.4.1. External SNS Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Sacral Nerve Stimulation Market: Applications Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Sacral Nerve Stimulation Market: Applications Movement Analysis, 2023 & 2030 (USD Million)
5.3. Urinary and Fecal Incontinence
5.3.1. Urinary and Fecal Incontinence Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Chronic Anal Fissure
5.4.1. Chronic Anal Fissure Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Urge Incontinence
5.5.1. Urge Incontinence Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Sacral Nerve Stimulation Market: Regional Estimates & Trend Analysis
6.1. Sacral Nerve Stimulation Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Russia
6.3.7.1. Russia Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. China
6.4.2.1. China Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Japan Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. South Korea
6.4.5.1. South Korea Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Australia
6.4.6.1. Australia Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Singapore
6.4.7.1. Singapore Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. Colombia
6.5.4.1. Colombia Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. UAE
6.6.3.1. UAE Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. South Africa
6.6.4.1. South Africa Sacral Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Medtronic
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Axonics, Inc.
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Boston Scientific Corporation
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Nervo Corp.
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Stimwave Technologies Inc.
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. St. Jude Medical
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Congentix Medical
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
